Obesity care follows guidelines

Obesity care is moving away from generic diet advice and toward guideline-based treatment plans that match therapy to a patient’s health risks and prior response. (ajmc.com) A December 14, 2022 review in *The American Journal of Managed Care* said two adult frameworks still anchor care: the 2013 American College of Cardiology, American Heart Association, and The Obesity Society guideline, and the 2016 American Association of Clinical Endocrinologists and American College of Endocrinology guideline. (ajmc.com) That review said both guidelines treat obesity as a chronic disease that needs screening, diagnosis, goals, and follow-up, not a single instruction to “eat less and move more.” (ajmc.com) The older American College of Cardiology, American Heart Association, and The Obesity Society guideline uses body mass index thresholds to trigger treatment decisions, while the endocrinology group’s guideline adds complications such as diabetes, sleep apnea, and cardiovascular risk when choosing care. (ajmc.com) (pro.aace.com) The endocrinology guideline is organized around screening, diagnosis, clinical evaluation, treatment options, therapy selection, and treatment goals, and the group now also lists a 2025 update algorithm for adults with obesity or adiposity-based chronic disease. (pro.aace.com 1) (pro.aace.com 2) Drug treatment has also been folded into formal guidance. The American Gastroenterological Association’s 2022 guideline said anti-obesity medications improve outcomes and is intended to help clinicians decide when to use pharmacologic treatment for overweight and obesity. (gastrojournal.org) Guidelines for children have shifted too. The American Academy of Pediatrics published its first clinical practice guideline for evaluating and treating children and adolescents with overweight and obesity in January 2023 and said care should account for the child’s health status, family system, community context, and treatment resources. (publications.aap.org 1) (publications.aap.org 2) The review’s core point is that obesity treatment is being structured more like hypertension or diabetes care: assess severity, check for complications, choose among lifestyle treatment, drugs, or surgery, and adjust over time. (ajmc.com) (pro.aace.com) That leaves less room for one-size-fits-all counseling and more room for formal pathways that tell clinicians who should get intensive behavioral treatment, who may benefit from medication, and who should be evaluated for bariatric surgery. (ajmc.com)